For instance, Nevirapine associated hepatotoxicity increases in patients with higher CD4 count [5, 27] while Zidovudine associated anemia [5] and Stavudine associated lipodystrophy is higher in patients with lower CD4 count [28, 29]. This evidence concerns the gene CD4 and lipodystrophy.